4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-085669
Chief Executive Officer sold 9,731 shares at $0.75 ($7,299)
From the SEC's structured data for this filing
Trades in this filing
Brainard Diana · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-07-19 | Sale : show line 1 in the form | −9,731 | $0.75 | $7,299 | 773,251 | D |
| Open-market sales · 9,731 sh · avg $0.75 · $7,299 | ||||||
Loading xslF345X05/ownership.xml…